Your browser doesn't support javascript.
loading
Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (helping end addiction long-term®) communities study.
Knudsen, Hannah K; Walker, Daniel M; Mack, Nicole; Kinnard, Elizabeth N; Huerta, Timothy R; Glasgow, LaShawn; Gilbert, Louisa; Garner, Bryan R; Dasgupta, Anindita; Chandler, Redonna; Walsh, Sharon L; Tin, Yjuliana; Tan, Sylvia; Sprunger, Joel; Sprague-Martinez, Linda; Salsberry, Pamela; Saucier, Merielle; Rudorf, Maria; Rodriguez, Sandra; Oser, Carrie B; Oga, Emmanuel; Nakayima, Julie; Linas, Beth S; Lefebvre, R Craig; Kosakowski, Sarah; Katz, Rachel E; Hunt, Timothy; Holman, Ari; Holloway, JaNae; Goddard-Eckrich, Dawn; Fareed, Naleef; Christopher, Mia; Aldrich, Alison; Adams, Joella W; Drainoni, Mari-Lynn.
Afiliación
  • Knudsen HK; Department of Family and Community Medicine, Ohio State University, Suite 5000, 700 Ackerman Rd, Columbus, OH 43202, USA. Electronic address: hkknud2@uky.edu.
  • Walker DM; Department of Family and Community Medicine, Ohio State University, Suite 5000, 700 Ackerman Rd, Columbus, OH 43202, USA. Electronic address: daniel.walker@osumc.edu.
  • Mack N; Center for Official Statistics, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: nmack@rti.org.
  • Kinnard EN; Section of Infectious Diseases, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, 801 Massachusetts Avenue, Boston, MA 02118, USA. Electronic address: elizabeth.kinnard@bmc.org.
  • Huerta TR; CATALYST, Center for the Advancement of Team Science, Analytics, and Systems Thinking, Department of Family and Community Medicine, Department of Biomedical Informatics, The Ohio State University, 540 W. Spring St., Columbus, OH 43215, USA. Electronic address: timothy.huerta@osumc.edu.
  • Glasgow L; Center for Program and Policy Evaluation to Advance Community Health, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: lglasgow@rti.org.
  • Gilbert L; School of Social Work, Columbia University, 1255 Amsterdam Ave., New York, NY 10027, USA. Electronic address: lg123@columbia.edu.
  • Garner BR; Department of Internal Medicine, The Ohio State University, 2050 Kenny Road Columbus, OH 43221, USA. Electronic address: bryan.garner@osumc.edu.
  • Dasgupta A; School of Social Work, Columbia University, 1255 Amsterdam Ave., New York, NY 10027, USA. Electronic address: ad3341@columbia.edu.
  • Chandler R; National Institute on Drug Abuse, 301 North Stonestreet Ave, Bethesda, MD 20892, USA. Electronic address: redonna.chandler@nih.gov.
  • Walsh SL; Department of Behavioral Science and Center on Drug and Alcohol Research, University of Kentucky, 845 Angliana Avenue, Room 202, Lexington, KY 40508, USA. Electronic address: sharon.walsh@uky.edu.
  • Tin Y; General Internal Medicine, University of Colorado School of Medicine, 12631 E 17th Ave Aurora, CO 80045, USA. Electronic address: yjuliana.tin@cuanschutz.edu.
  • Tan S; Center for Clinical Research, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: stan@rti.org.
  • Sprunger J; Center for Addiction Research, University of Cincinnati College of Medicine, 3131 Harvey Ave, Suite 204, Cincinnati, OH 45229, USA. Electronic address: joel.sprunger@uc.edu.
  • Sprague-Martinez L; School of Social Work, Boston University, 264 Bay State Road, Boston, MA 02215, USA. Electronic address: lsmarti@bu.edu.
  • Salsberry P; College of Public Health, The Ohio State University, 1841 Neil Avenue, Columbus, OH 43210, USA. Electronic address: salsberry.1@osu.edu.
  • Saucier M; Clinical Addiction Research and Evaluation Unit, Section of General Internal Medicine, Boston Medical Center, 801 Massachusetts Avenue, Boston, MA 02118, USA. Electronic address: MerielleSaucier@gmail.com.
  • Rudorf M; General Internal Medicine, Boston Medical Center, 801 Massachusetts Avenue, Boston, MA 02118, USA. Electronic address: maria.rudorf@bmc.org.
  • Rodriguez S; School of Social Work, Columbia University, 1255 Amsterdam Ave., New York, NY 10027, USA. Electronic address: sr3717@columbia.edu.
  • Oser CB; Department of Sociology, Center on Drug & Alcohol Research, Center for Health Equity Transformation, University of Kentucky, 1531 Patterson Office Tower, Lexington, KY 40506, USA. Electronic address: carrie.oser@uky.edu.
  • Oga E; Center for Public Health Surveillance and Technology, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: eoga@rti.org.
  • Nakayima J; Center on Drug and Alcohol Research, University of Kentucky, 845 Angliana Avenue, Lexington, KY 40508, USA. Electronic address: julie.nakayima@uky.edu.
  • Linas BS; Center for Public Health Surveillance and Technology, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: blinas@rti.org.
  • Lefebvre RC; Communication Practice Area, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: clefebvre@rti.org.
  • Kosakowski S; General Internal Medicine, Boston Medical Center, 801 Massachusetts Avenue, Boston, MA 02118, USA. Electronic address: sarah.kosakowski@bmc.org.
  • Katz RE; Addiction Services, Clinical & Support Options, 8 Atwood Dr Suite 201, Northampton, MA 01060, USA. Electronic address: rachelkatznp@gmail.com.
  • Hunt T; School of Social Work, Columbia University, 1255 Amsterdam Ave., New York, NY 10027, USA. Electronic address: th2258@columbia.edu.
  • Holman A; School of Social Work, Columbia University, 1255 Amsterdam Ave., New York, NY 10027, USA. Electronic address: ah3735@columbia.edu.
  • Holloway J; Center for Clinical Research, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: jlholloway@rti.org.
  • Goddard-Eckrich D; School of Social Work, Columbia University, 1255 Amsterdam Ave., New York, NY 10027, USA. Electronic address: dg2121@columbia.edu.
  • Fareed N; Biomedical Informatics, The Ohio State University, 370 W. 9th Avenue, Columbus, OH 43210, USA. Electronic address: Naleef.fareed@osumc.edu.
  • Christopher M; Center for Public Health Surveillance and Technology, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: mchristopher@rti.org.
  • Aldrich A; CATALYST, Center for the Advancement of Team Science, Analytics, and Systems Thinking, The Ohio State University, Suite 5000, 700 Ackerman Rd, Columbus, OH 43202, USA. Electronic address: alison.aldrich@osumc.edu.
  • Adams JW; Center for Public Health Surveillance and Technology, RTI International, 3040 East Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA. Electronic address: jadams@rti.org.
  • Drainoni ML; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine/Boston Medical Center, and Department of Health Law, Policy and Management, Boston University School of Public Health, 801 Massachusetts Avenue, Room 2014, Boston, MA, 02118, USA. Ele
Prev Med ; 185: 108034, 2024 Jun 08.
Article en En | MEDLINE | ID: mdl-38857770
ABSTRACT

BACKGROUND:

Scaling up overdose education and naloxone distribution (OEND) and medications for opioid use disorder (MOUD) is needed to reduce opioid overdose deaths, but barriers are pervasive. This study examines whether the Communities That HEAL (CTH) intervention reduced perceived barriers to expanding OEND and MOUD in healthcare/behavioral health, criminal-legal, and other/non-traditional venues.

METHODS:

The HEALing (Helping End Addiction Long-Term®) Communities Study is a parallel, wait-list, cluster randomized trial testing the CTH intervention in 67 communities in the United States. Surveys administered to coalition members and key stakeholders measured the magnitude of perceived barriers to scaling up OEND and MOUD in November 2019-January 2020, May-June 2021, and May-June 2022. Multilevel linear mixed models compared Wave 1 (intervention) and Wave 2 (wait-list control) respondents. Interactions by rural/urban status and research site were tested.

RESULTS:

Wave 1 respondents reported significantly greater reductions in mean scores for three

outcomes:

perceived barriers to scaling up OEND in Healthcare/Behavioral Health Venues (-0.26, 95% confidence interval, CI -0.48, -0.05, p = 0.015), OEND in Other/Non-traditional Venues (-0.53, 95% CI - 0.84, -0.22, p = 0.001) and MOUD in Other/Non-traditional Venues (-0.34, 95% CI -0.62, -0.05, p = 0.020). There were significant interactions by research site for perceived barriers to scaling up OEND and MOUD in Criminal-Legal Venues. There were no significant interactions by rural/urban status.

DISCUSSION:

The CTH Intervention reduced perceived barriers to scaling up OEND and MOUD in certain venues, with no difference in effectiveness between rural and urban communities. More research is needed to understand facilitators and barriers in different venues.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Prev Med Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Prev Med Año: 2024 Tipo del documento: Article